BIOMAT Database Logo BIOMAT Database Logo

Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis [proceedings]. 1977

T N Calvey, and K Chan

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D011729 Pyridostigmine Bromide A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mestinon,Pyridostigmine,Bromide, Pyridostigmine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T N Calvey, and K Chan
Plasma pyridostigmine levels in myasthenia gravis.
February 1981, Neurology,
T N Calvey, and K Chan
Malabsorption of pyridostigmine in patients with myasthenia gravis.
March 1977, Neurology,
T N Calvey, and K Chan
Treatment of myasthenia gravis with pyridostigmine.
October 1987, Archives of neurology,
T N Calvey, and K Chan
Pyridostigmine levels in myasthenia gravis.
November 1977, Neurology,
T N Calvey, and K Chan
Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis.
May 1985, Clinical pharmacology and therapeutics,
T N Calvey, and K Chan
Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.
October 1983, Journal of neurology, neurosurgery, and psychiatry,
T N Calvey, and K Chan
[Treatment of myasthenia gravis with pyridostigmine (mestinon)].
August 1955, Revista clinica espanola,
T N Calvey, and K Chan
Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis.
October 1995, Thorax,
T N Calvey, and K Chan
The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis.
December 1981, Journal of neurology, neurosurgery, and psychiatry,
T N Calvey, and K Chan
Mestinon (pyridostigmine bromide) in myasthenia gravis.
July 1956, Canadian Medical Association journal,
Copied contents to your clipboard!